Clinical Trial Update: Phase I/II Study of AloCelyvir in Patients With Metastatic Uveal Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II clinical trial update for AloCelyvir in metastatic uveal melanoma is in early-phase stages with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Drugs mentioned

• AloCELYVIR

Snippet

Sponsor: José María Piulats Rodríguez | Conditions: Uveal Melanoma, Metastatic | Phase 1, Phase 2 | Status: UNKNOWN